ErgoSteel (ES0001/696)
Strongback Mobility AG C/O Blueaudit GmbH · Decision date Sep 22, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on September 22, 2026 for K253762, submitted by Strongback Mobility AG C/O Blueaudit GmbH under product code IOR in the Physical Medicine specialty. The subject is the STRONGBACK ErgoSteel Wheelchair, described in the decision letter as a folding wheelchair. The 510(k) record lists a receipt date of 11/25/2025 and regulation number 890.385023. SESE means the device was cleared for marketing as substantially equivalent; it is not a PMA approval.
The decision letter excerpt refers to an OEM manufacturer operating under an ISO 13485:2016 certified quality management system, but the excerpt does not name that manufacturer or identify which components or changed items were assessed. The predicate device, the specific comparison basis for the equivalence finding, and any labeling or testing details are not present in the available text. The listed applicant contact is Roman Hefle, with the address given as Schindellegistrasse 73, 8808 Pfaeffikon, Switzerland.
No clinical performance data, indications wording, or post-market obligations appear in the retrieved material, so none are characterized here. Readers needing the predicate identification, technological comparison, or cleared labeling should consult the full FDA decision document rather than this summary.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Physical Medicine
- Decision date
- Sep 22, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K253762
- Regulatory pathway
- 510(k) premarket notification
- Product code
- IOR
- Decision code
- SESE
- Decision date
- Sep 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Wheelchair, Mechanical.
- Product code
- IOR
- FDA device class
- 1
FDA decision timeline
K253762 received
Application receipt date recorded by FDA.
K253762 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code IOR
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Zhenjiang Assure Medical Equipment Co., Ltd. | 510(k) clearance | Sep 16, 2026 | FDA | |
| Zhenjiang Assure Medical Equipment Co., Ltd. | 510(k) clearance | Sep 15, 2026 | FDA | |
| Zhenjiang Assure Medical Equipment Co., Ltd. | 510(k) clearance | Sep 15, 2026 | FDA | |
YJ-K1K2 Wheelchair (YJ-013F)K260145 | Zhenjiang Assure Medical Equipment Co., Ltd. | 510(k) clearance | Sep 15, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Strongback Mobility AG C/O Blueaudit GmbH
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Pfaeffikon
Sources and methodology
- Original FDA record: K253762
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


